Bazedoxifene is a selective estrogen receptor modulator (SERM), under developed by Wyeth Pharmaceuticals for the prevention and treatment of postmenopausal osteoporosis and the result of an exclusive research collaboration with Ligand Pharmaceuticals.
Bazedoxifene is a selective estrogen receptor modulator (SERM). This is under. Bazedoxifene was developed by Wyeth Pharmaceuticals for the prevention and treatment of postmenopausal osteoporosis with Ligand Pharmaceuticals. Bazedoxifene was developed by Wyeth Pharmaceuticals for the result of an exclusive research collaboration with Ligand Pharmaceuticals.